Eyelids oedema as a manifestation of IgG4-related disease: case report and literature review

1 Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020;369:m1067. doi: 10.1136/bmj.m1067. Search in Google Scholar

2 Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 2019;78(3):406-12. doi: 10.1136/annrheumdis-2018-214603. Search in Google Scholar

3 Andrew NH, Sladden N, Kearney DJ, Selva D. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol 2015;99(3):376-81. doi: 10.1136/bjophthalmol-2014-305545. Search in Google Scholar

4 Yeşiltaş, YS; Gündüz AK. Idiopathic orbital inflammation: review of literature and new advances. Middle East Afr J Ophthalmol 2018;25(2):71-80. doi: 10.4103/meajo.MEAJO_44_18. Search in Google Scholar

5 Lai KKH, Aljufairi FMAA, Sebastian JU, Yip CCY, Wei Y, Jia R, et al. Systemic involvement in immunoglobulin G4-related ophthalmic disease. Ocul Immunol Inf lamm 2024;32(8):1852-8. doi: 10.1080/09273948.2023.2280709. Search in Google Scholar

6 Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4--related disease: Single-center experience and literature review. Semin Arthritis Rheum 2014;43(6):806-17. doi: 10.1016/j.semarthrit.2013.11.008. Search in Google Scholar

7 Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol 2014;71(6):785-93. doi: 10.1001/jamaneurol.2014.243. Search in Google Scholar

8 Prabhu SM, Yadav V, Irodi A, Mani S, Varghes AM. IgG4-related disease with sinonasal involvement: A case series. Indian J Radiol Imaging 2014;24(2):117-20. doi: 10.4103/0971-3026.134384. Search in Google Scholar

9 Mulholland GB, Jeffery CC, Satija P, Côté DWJ. Immunoglobulin G4-related diseases in the head and neck: a systematic review. J Otolaryngol Head Neck Surg 2015;44(1):24. doi: 10.1186/s40463-015-0071-9. Search in Google Scholar

10 Opriţă R, Opriţă B, Berceanu D, Diaconescu IB. Overview of IgG4 – related disease. J Med Life 2017;10(4):203-7. Search in Google Scholar

11 Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012;2012:580814. doi: 10.1155/2012/580814. Search in Google Scholar

12 Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 2015;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907. Search in Google Scholar

13 Yamada K, Yamamoto M, Saeki T, Mizushima I, Matsui S, Fujisawa Y, et al. New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases. Arthritis Res Ther 2017;19(1):262. doi: 10.1186/s13075-017-1467-x. Search in Google Scholar

14 Kasashima S, Kawashima A, Kasashima F, Endo M, Matsumoto Y, Kawakami K. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart Vessels 2018;33(12):1471-81. doi: 10.1007/s00380-018-1203-8. Search in Google Scholar

15 Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4‐related disease. Allergy 2014;69(2):269-72. Search in Google Scholar

16 Martín-Nares E, Hernandez-Molina G. What is the meaning of ANCA positivity in IgG4-related disease? Rheumatology (Oxford) 2021;60(8):3845-50. doi: 10.1093/rheumatology/keab124. Search in Google Scholar

17 Hara S, Nuka H, Horita S, Zoshima T, Ito K, Aizu M, et al. AB1171 clinical significance of anti-nuclear antibodies in IGG4-related disease. Ann Rheum Dis 2015;74:1294-5. Search in Google Scholar

18 Peng L, Lu H, Zhou J, Zhang P, Li J, Liu Z, et al. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study. Arthritis Res Ther 2021;23(1):102. doi: 10.1186/s13075-021-02481-3. Search in Google Scholar

19 Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25(9):1181-92. doi: 10.1038/modpathol.2012.72. Search in Google Scholar

20 Fujita A, Sakai O, Chapman MN, Sugimoto H. IgG4-related disease of the head and neck: CT and MR imaging manifestations. Radiographics 2012;32(7):1945-58. doi: 10.1148/rg.327125032. Search in Google Scholar

21 Tomiyama T, Uchida K, Matsushita M, Ikeura T, Fukui T, Takaoka M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol 2011;46(5):696-704. doi: 10.1007/s00535-010-0361-y. Search in Google Scholar

22 Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 2015;67(7):1688-99. doi: 10.1002/art39132. Search in Google Scholar